Benjamin Graham · Inversión deep-value defensiva
Is Xeris Biopharma Holdings, Inc. (XERS) a Benjamin Graham Stock?
Meets 2/7 Graham criteria, classic deep-value candidate.
79/100
No encaja
2/7 criterios cumplidos
Los criterios de Benjamin Graham, aplicados a XERS
P/E ≤ 15
clave92.7x
P/B ≤ 1.5
clave85.6x
Current ratio ≥ 2
2.1x
Debt / Equity ≤ 1
2.9x
Cómo se valora XERS en otras estrategias
Datos financieros en vivo
Cap. mercado
$1.85B
PER (TTM)
92.7x
ROIC (TTM)
12.84%
Margen bruto
81.59%
Otros análisis Benjamin Graham
Preguntas frecuentes
What is XERS's Benjamin Graham fit score?
XERS scores 79/100 on our Benjamin Graham fit engine. Meets 2/7 Graham criteria, classic deep-value candidate.
Does Benjamin Graham actually own XERS?
Our score is computed from financial fundamentals against Benjamin Graham's published criteria. We don't claim that Benjamin Graham personally owns or recommends XERS.
How often is this score updated?
XERS's Benjamin Graham fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Herramienta educativa, no es asesoramiento financiero. Las puntuaciones se calculan a partir de datos financieros públicos contra los criterios publicados de cada estrategia de inversión. No afirmamos que Benjamin Graham posea o recomiende XERS personalmente.
